Treatment of G1 Duodenal Neuroendocrine Tumors With Hepatic Metastasis: A Case Report
HAIC-FOLFOX combined with lenvatinib induced complete liver metastasis response and partial primary tumor response in G1 duodenal neuroendocrine tumor, enabling curative resection (13 months recurrence free survival), highlighting a novel conversion strategy for advanced dNETs with liver metastases.
Authors
- Ruiqin Huang
- Kun He (ORCID: https://orcid.org/0000-0002-1510-860X)
- Dongdong Huang (ORCID: https://orcid.org/0009-0006-6408-0910)
- Qijie Luo (ORCID: https://orcid.org/0009-0009-6446-5839)
- Yuquan Chang
- Feng Tian
- Yilin Qiu
- Yuhui Fang
Institutions
- Guangdong Medical College (CN)
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Clinical Case Reports
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1002/ccr3.71764
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00